Lundbeck
Tracked across 2 events · 14 articles · First seen Mar 10, 2026 · Last active Mar 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Lundbeck A/S appointed Markus Kede as its Chief AI Officer, signaling a strategic move to integrate AI across its operations and become a 'bionic company'. This appointment is expected to enhance research, development, and commercial execution, strengthening Lundbeck's long-term competitiveness.
Mar 10, 2026 · 7 articles
Tech
Lundbeck A/S announced positive Phase 1b data for Lu AF28996, an investigational treatment for advanced Parkinson s disease, and will present these findings at the 2026 AD/PD™ Conference. This supports the continued clinical development of the compound and highlights Lundbeck's growing pipeline in movement disorders, including amlenetug for multiple system atrophy.
Mar 16, 2026 · 7 articles
Johan Luthman
EVP and Head of Research & Development
↔
Lundbeck
Johan Luthman is an executive at Lundbeck A/S.
NEWSDESK
Track Lundbeck live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard